Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective.

Autor: Walters, S.J.1, Whitfield, M.1, Akehurst, R.L.1, Chilcott, J.B.1, Walters, Stephen J1 (AUTHOR), Whitfield, Malcolm (AUTHOR), Akehurst, Ronald L (AUTHOR), Chilcott, James B (AUTHOR)
Zdroj: PharmacoEconomics. 2003, Vol. 21 Issue 2, p129-138. 10p. 1 Diagram, 6 Charts.
Databáze: Business Source Ultimate
Externí odkaz: